Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Author
CADTH Canadian Drug Expert Committee
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Showing
1
-
20
of
204
Search:
'CADTH Canadian Drug Expert Committee'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
7
CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
8
CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) : indication: in adults, as an adjunct to standard of care therapy, for the...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Nintedanib (Ofev -- Boehringer Ingelheim Canada Inc.) : indication: chronic fibrosing interstitial lung diseases
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
12
Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Tofacinitib (Xeljanz) : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Esketamine (Spravato -- Janssen inc.) : indication: for the treatment of major depressive disorder in adults
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
17
Optimal use of minimally invasive glaucoma surgery: Recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC) : indication : for the treatment of adult patients with cardiomyopathy due t...
Published 2020
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
1
2
3
4
5
6
7
8
9
10
11
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Author/Home?author=%22CADTH+Canadian+Drug+Expert+Committee%22&type=Author
Send by Email
×
Loading...